Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy.

Journal:
Radiology
Published:
DOI:
10.1148/radiol.251698
Affiliations:
2
Authors:
9
Go to article
Institutions Authors Share
The People's Liberation Army General Hospital (PLAGH), China
5.000000
 0.56
The First Medical Center, PLAGH, China
4.000000
 0.44
Interested in Clinical Sciences?